Terms: = Lymphoma AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Treatment
590 results:
1. Evaluation of the cardiac safety of parsaclisib, a selective PI3Kδ inhibitor, in patients with previously treated B-cell malignancies: Results from the CITADEL-101 study.
Li J; Gong X; Liu X; Liu X; Szeto K; Chen X
Pharmacol Res Perspect; 2024 Apr; 12(2):e1165. PubMed ID: 38407508
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
[No Abstract] [Full Text] [Related]
3. Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
[TBL] [Abstract] [Full Text] [Related]
4. Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Ollivier L; Debbi K; To NH; Cailleteau A; Supiot S; Mervoyer A; Guimas V; Belkacémi Y
Cancer Radiother; 2024 Feb; 28(1):119-130. PubMed ID: 38143233
[TBL] [Abstract] [Full Text] [Related]
5. A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.
Enshaei A; Joy M; Butler E; Kirkwood AA; Messina M; Pavoni C; Morgades M; Harrison CJ; Foà R; Ribera JM; Chiaretti S; Bassan R; Fielding AK; Moorman AV
Blood Adv; 2024 Mar; 8(5):1155-1166. PubMed ID: 38113467
[TBL] [Abstract] [Full Text] [Related]
6. Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström's Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study.
Yi S; Cai Z; Hu Y; He A; Gao S; Li Q; Sha L; Zhang N; Ren Y; Gai X; Yang X; Qin R; Qiu L
Adv Ther; 2024 Feb; 41(2):672-685. PubMed ID: 38079089
[TBL] [Abstract] [Full Text] [Related]
7. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Hidaka M; Inokuchi K; Uoshima N; Takahashi N; Yoshida N; Ota S; Nakamae H; Iwasaki H; Watanabe K; Kosaka Y; Komatsu N; Meguro K; Najima Y; Eto T; Kondo T; Kimura S; Yoshida C; Ishikawa Y; Sawa M; Hata T; Horibe K; Iida H; Shimomura T; Dobashi N; Sugiura I; Makiyama J; Miyagawa N; Sato A; Ito R; Matsumura I; Kanakura Y; Naoe T
Jpn J Clin Oncol; 2024 Feb; 54(2):153-159. PubMed ID: 37986553
[TBL] [Abstract] [Full Text] [Related]
8. Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects.
Meijer SE; Halutz O; Adler A; Levytskyi K; Tau L; Dekel M; Cohen-Poradosu R; Katchman E; Shasha D; Ablin J; Choshen G; Jacob G; Wasserman A; Ingbir M; Cohen YC; Perry C; Ram R; Herishanu Y; Bar On Y; van Thijn E; Rutsinsky N; Harari S; Stern A; Ben-Ami R; Paran Y
J Infect Chemother; 2024 Mar; 30(3):271-275. PubMed ID: 37944697
[TBL] [Abstract] [Full Text] [Related]
9. An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib.
Attwa MW; Bakheit AH; Abdelhameed AS; Kadi AA
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894699
[TBL] [Abstract] [Full Text] [Related]
10. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
[TBL] [Abstract] [Full Text] [Related]
11.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
12. BCL-W makes only minor contributions to MYC-driven lymphoma development.
Diepstraten ST; La Marca JE; Chang C; Young S; Strasser A; Kelly GL
Oncogene; 2023 Sep; 42(37):2776-2781. PubMed ID: 37567974
[TBL] [Abstract] [Full Text] [Related]
13. Time Trend Analysis of Splenectomy for Splenic Marginal Zone lymphoma: Declining Surgery, Promising Survival.
Yang Z; Liu L; Leng K; Shi G
Ann Surg Oncol; 2023 Nov; 30(12):7206-7216. PubMed ID: 37516724
[TBL] [Abstract] [Full Text] [Related]
14. Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma.
Panjan M; Boltezar L; Novakovic S; Kokovic I; Jezersek Novakovic B
Radiol Oncol; 2023 Dec; 57(4):487-492. PubMed ID: 37439703
[TBL] [Abstract] [Full Text] [Related]
15. PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL.
Amitai I; Roos K; Rashedi I; Jiang Y; Mangoff K; Klein G; Forward N; Stewart D; Laneuville P; Bence-Bruckler I; Mangel J; Tomlinson G; Berinstein NL
Eur J Haematol; 2023 Aug; 111(2):191-200. PubMed ID: 37157906
[TBL] [Abstract] [Full Text] [Related]
16. The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.
Marinescu EC; Bumbea H; Iordan I; Dumitru I; Soare D; Ciufu C; Gaman M
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109629
[TBL] [Abstract] [Full Text] [Related]
17. Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results.
Lococo F; Cancellieri A; Chiappetta M; Leonetti A; Cardillo G; Zanelli F; Mangiameli G; Toschi L; Guggino G; Romano FJ; Leuzzi G; Proto C; Spaggiari L; De Marinis F; Vita E; Ampollini L; Margaritora S; Tiseo M; Bria E
Clin Lung Cancer; 2023 Jul; 24(5):467-473. PubMed ID: 37061413
[TBL] [Abstract] [Full Text] [Related]
18. Does variable RBE affect toxicity risks for mediastinal lymphoma patients? NTCP-based evaluation after proton therapy treatment.
Tommasino F; Cartechini G; Righetto R; Farace P; Cianchetti M
Phys Med; 2023 Apr; 108():102569. PubMed ID: 36989976
[TBL] [Abstract] [Full Text] [Related]
19. Markers of neutrophil chemotaxis for identification of blood stream infections in children with acute lymphoblastic leukemia undergoing induction treatment.
Weischendorff S; De Pietri S; Rathe M; Frandsen TL; Hasle H; Nielsen CH; Moser C; Müller K
Eur J Haematol; 2023 Jun; 110(6):762-771. PubMed ID: 36950865
[TBL] [Abstract] [Full Text] [Related]
20. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
Zobeck M; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
Pharmacotherapy; 2023 Mar; 43(3):205-214. PubMed ID: 36764694
[TBL] [Abstract] [Full Text] [Related]
[Next]
